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Chromatin remodeling enzymes act to dynamically regulate
gene accessibility. In many cases, these enzymes function as
large multicomponent complexes that in general comprise a
central ATP-dependent Snf2 family helicase that is decorated
with a variable number of regulatory subunits. The nucleosome
remodeling and deacetylase (NuRD) complex, which is essential
for normal development in higher organisms, is one such
macromolecular machine. The NuRD complex comprises
10 subunits, including the histone deacetylases 1 and 2
(HDAC1 and HDAC2), and is defined by the presence of a
CHD family remodeling enzyme, most commonly CHD4
(chromodomain helicase DNA-binding protein 4). The exist-
ing paradigm holds that CHD4 acts as the central hub upon
which the complex is built. We show here that this paradigm
does not, in fact, hold and that CHD4 is a peripheral compo-
nent of the NuRD complex. A complex lacking CHD4 that has
HDAC activity can exist as a stable species. The addition of
recombinant CHD4 to this nucleosome deacetylase complex
reconstitutes a NuRD complex with nucleosome remodeling
activity. These data contribute to our understanding of the
architecture of the NuRD complex.
Nucleosomes effectively act as a roadblock to all aspects
of genome biology. ATP-dependent chromatin remodeling
enzymes solve this problem by using ATP-derived energy to
alter the positions, occupancy and composition of nucleo-
somes. All remodelers possess a highly related ATPase motor
domain from the helicase family and are classified into four
subfamilies (INO80, ISWI, SWR1, and CHD) based on
sequence similarity (1). Each subfamily is represented in nearly
all eukaryotes, suggesting that they catalyze different remodel-
ing events. For example, ISWI proteins reposition (or slide)
nucleosomes to create regularly spaced arrays; this periodic
organization is a key characteristic of DNA at the start of genes
(2). SWR1 and INO80 enzymes have opposing roles in histone
variant dynamics; the former incorporates these histone vari-
ants (e.g.H2A.Z), whereas the latter removes them. These vari-
ants set up specific chromatin structures that modulate tran-
scription and replication, although the roles of many variants
are still under debate (3). Fundamentally, these remodeling
enzymes all alter the accessibility of DNA to other DNA-bind-
ing factors and thereby broadly underpin genome biology.
Remodelers frequently act in the context of large multisub-
unit complexes, and in general, the “mixing and matching” of
complex composition can generate complexes with varying
activities; the human ISWI protein Snf2h for instance has been
identified in six distinct complexes (4). Likewise, the accessory
subunits can also modulate remodeler activity. For example,
the paralogous methyl-CpG-binding domain proteins 2 and 3
(MBD2 and MBD3) subunits of the nucleosome remodeling
and deacetylase (NuRD)6 complex are mutually exclusive (5);
MBD2 recognizes 5-methylcytosine-modified DNA, whereas
MBD3 instead binds to 5-hydroxymethylated DNA (6, 7).
Unsurprisingly, it has been observed that MBD2 guides the
NuRD complex to repressed, methylation-rich loci in the
genome, whereasMBD3has been observed to localize to active,
unmethylated chromatin (8).
Although there have been considerable advances made in
our understanding of the structure and function of chromatin
remodeling complexes, a detailed mechanistic description
of remodeling is still lacking, and no high resolution structures
of remodeling complexes are available. A number of low reso-
lution models of these remodeling complexes (23–50 Å)
derived from single-particle electron microscopy and cryo-EM
data have been reported (9–17); these models reveal some
diversity in the overall shape of each complex, but a common
feature is the integral nature of the remodeling subunit. For
example, in the recent INO80 and SWR1 structures, the Ino80
and Swr1 ATPases lie at the center of the corresponding com-
plex and are decorated with sets of regulatory subunits (14, 16).
The NuRD complex is a broadly expressed chromatin
remodeling complex that is found only in complex organisms
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and that has important roles in gene regulation (18) and DNA
repair (19). NuRD activity is essential at all stages of hemato-
poiesis, regulating both hematopoietic stem cell maintenance
and differentiation of these cells into distinct lineages (20–22).
Aberrant expression ofNuRD subunits is also strongly linked to
cancer (23), and the down-regulation of several NuRD compo-
nents induces changes in chromatin structure that are associ-
ated with aging (24). NuRD is also emerging as a significant and
perhaps controversial player in efforts to reprogram somatic
cells into pluripotent stem cells (25–27).
The most frequently observed subunits of the NuRD com-
plex are a remodeler (CHD4, CHD3, or CHD5); the histone
deacetylases HDAC1 and HDAC2; the WD40 repeat proteins
RBBP4 and RBBP7; the metastasis-associated proteins MTA1,
MTA2, andMTA3; the poorly defined proteinsGATAD2Aand
GATAD2B; and the methyl-DNA binding domain proteins
MBD2 and MBD3. In each case, the alternative proteins are
closely related (e.g. human HDAC1 and HDAC2 are 86% iden-
tical), and overall we know very little about the relative distri-
butions of these orthologues in the complex and what func-
tional changes might be imparted by changes in subunit
composition.
Three structures of subcomplexes have been reported: (i)
HDAC1bound to a fragment ofMTA1 (28); (ii) a dimeric coiled
coil formedby40-residue segments ofGATAD2AandMBD2
(29); and (iii) RBBP4 bound to a short peptide fromMTA1 (30).
Stoichiometry data derived from label-free mass spectrometry
measurements also provide hints about the number of copies of
each subunit that come together in the complex (31, 32),
although themass spectrometric data do not seem entirely con-
sistent with the structural data. However, in contrast to the
remodeling complexes described above, nothing is known
about the overall architecture of the NuRD complex (Note
added in proof).
NuRD is invariably depicted in the literature as a multisub-
unit complex with the remodeling subunit CHD4 as the central
hub protein (18, 33–35). This interpretation is consistent with
the structures of other chromatin remodeling complexes such
as SWR1 and INO80. Here, we demonstrate that CHD4 is in
fact a peripheral component of the NuRD complex and that an
otherwise fully intact complex with histone deacetylase activity
can exist, at least in vitro, in the absence of CHD4. These data
suggest that theNuRD complexmight act via amechanism that
is distinct from other remodeling complexes and perhaps pro-
vides a mechanism by which CHD4 can disengage easily from
NuRD to carry out functions independent of the remainder of
the complex.
Results
NuRD Forms a Stable Complex in the Absence of CHD4—In
previous work, Hong et al. (36) demonstrated that the NuRD
complex could be purified from murine erythroleukemia
(MEL) cell extracts by a single-step affinity chromatography
method using an N-terminal GST fusion of the first 45 residues
of the transcriptional co-regulator FOG1(1–45) (Friend of
GATA1). It was further shown that this FOG1-NuRD interac-
tion appears to be mostly mediated by the MTA and RBBP
family proteins (36, 37). Recently, we showed that good purifi-
cation could be achieved using a synthetic version of FOG1(1–
15) with a C-terminal fusion of the StreptagII peptide affinity
tag and a fluorescein moiety (for ease of detection purposes)
(38). Importantly, using these FOG1 affinity chromatography
methods, relatively clean NuRD preparations can be achieved
despite the fact that several components of the NuRD complex
(e.g. HDACs and RBBPs) are also key components in other
complexes, such as the SIN3 deacetylase complex.
In these purifications, we always observe the following pro-
teins: MTA1/2/3, GATAD2A/B. HDAC1/2, RBBP4/7, and
MBD3. We also observe CHD4 but find that the amount of
CHD4 is quite variable, compared with the other subunits. Fig.
1 shows that although the relative amounts ofMTA, GATAD2,
HDAC, and RBBP family subunits are quite consistent between
different NuRD preparations, the amount of CHD4 varies dra-
matically (note that MBD3 stains poorly). In some cases, little
or no CHD4 was observed (e.g. right-hand lane in Fig. 1A). Gel
image quantification show large variations in intensity for
CHD4, of the order of several hundred percent, relative to other
NuRD components (Fig. 1B). This observation led us to pro-
pose that a stable NuRD-type complex can form in the absence
of CHD4.We named this assembly the nucleosome deacetylase
complex (NuDe).
FIGURE 1.NuRDpurifies fromMEL cells asCHD4 andCHD4 species. A,
SDS-PAGEshowing thecore componentsof theNuRDcomplexpurifiedusing
FOG1 affinity chromatography. Comparison of intensities reveals that the
relative amount of CHD4 varies substantially from lane to lane. In particular,
culture time (number of days) appears to affect the amount of CHD4 associ-
ated with NuRD. B, SYPRO-Ruby-stained band intensities from the gel in A
were quantified using the ImageJ software package. The data from all eight
pulldowns are shown (gray dots). Themean values are depicted by themiddle
black lines, and the ends of the whiskers depict the standard deviation for a
givenprotein. The large standard deviation of intensities for CHD4, relative to
the other bands, suggests that CHD4 occupancy in the NuRD complex is
highly variable and does not track together with the other components.
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To investigate this observation further, we performed in vitro
chemical cross-linking of the NuRD complex purified by FOG1
affinity chromatography. Fig. 2 (left-hand gel) shows clearly
that the addition of the cross-linker disuccinimidyl suberate to
our NuRD complex results in two distinct high molecular
weight bands that run into the gel (and are therefore unlikely to
represent nonspecifically cross-linked multimers). Cross-link-
ing of a separate preparation (right-hand gel) that contains sub-
stantially less CHD4 (judging from the pre-cross-linked lane)
shows the same two bands but with quite different relative
intensities: the higher molecular weight band is of much lower
intensity, consistent with the formation of a complex lacking
CHD4. Blue native PAGE of the affinity-purified complex
(without cross-linking) revealed two major bands at900 and
720 kDa (Fig. 3A). The apparent mass difference is consistent
with the molecular mass of CHD4 (218 kDa).
We next sought to determine the composition of these com-
plexes by running the blue native gel lane from Fig. 3A in a
reducing SDS-PAGE as a second dimension. As shown in Fig.
3B, the 900-kDa band has bands visible for all components of
the NuRD complex. In contrast, the 720-kDa band yielded all
components except for CHD4. The same conclusion is reached
when the purified complex (bound to fluorescein-labeled
FOG1(1–15)) is subjected to sucrose density gradient ultracen-
trifugation; fluorescent signals corresponding to NuDe and
NuRD were observed at two distinct positions in the gradient
(Fig. 4A). SDS-PAGE analysis of the gradient fractions (Fig. 4B)
in combination with dot blot analysis of the fractions (Fig. 4C)
confirms the existence of the lighter NuDe and the heavier
NuRD complexes. Finally, direct mass spectrometric analyses
of gel bands cut from the blue native PAGE (from Fig. 3A) and
digestedwith trypsin confirmed the presence of all components
of the NuRD complex in the 900-kDa band, whereas the 720-
kDa band lacked CHD4 but contained all other components
with similar levels of sequence coverage (Fig. 3C). Taken
together, these complementary lines of evidence suggest that,
even in the absence of CHD4, all other components of the
NuRD complex can assemble into a stable entity that is likely to
have the same subunit stoichiometry.
The NuDe Complex Has Robust Deacetylase Activity—The
observation of two distinct complexes raises questions about
the function of the smaller entity. We asked whether the NuDe
complex still possessed protein deacetylase activity; inactiva-
tion of NuRD following the loss of CHD4 could serve as an
effective form of functional regulation of the complex.We per-
formed HDAC activity assays on purified NuDe complex (cal-
culated to contain only1–2% NuRD). As shown in Fig. 5, the
NuDe complex possesses robust deacetylase activity. When
compared with the manufacturer-supplied HDAC positive
control, the NuDe complex was approximately four times as
active.
NuRDCan Be Reconstituted by Adding CHD4 to NuDe—The
observation that CHD4 occupancy in the NuRD complex is
highly variable suggests that CHD4 is not in the core of the
complex but rather at the periphery.We reasoned that, if this is
the case, we should be able to supplement our NuDe complex
with heterologously produced CHD4 to reconstitute the full
NuRD complex.
For these CHD4 supplementation experiments, we used
FLAG-CHD4 transiently expressed in mammalian HEK293FT
cells. Despite its large size (218 kDa), we were able to express
and purify CHD4 (Fig. 6A). When we mixed HEK293FT
nuclear extracts containing FLAG-CHD4 with MEL cell
nuclear extracts prior to incubation with the FOG1-immobi-
lized beads, we observed that the occupancy of CHD4 was
increased in the complex (Fig. 6B). To calculate the proportion
of CHD4 in our NuDe/NuRD preparations, we sought to
account for differences between NuRD subunits in their gel
staining properties. We first determined the ratio of NuDe to
NuRD in each fraction taken from our sucrose gradient purifi-
cations of MEL cell-derived complex by fitting each fluores-
cence trace (from three independent sucrose gradients; e.g. as
shown in Fig. 4A) to a sum of two Lorentzians (Fig. 6C). Fig. 6D
shows the calculated molar ratio of NuRD to NuDe across dif-
ferent fractions. The NuRD:NuDe ratio was as high as80% in
some fractions.
We then measured the intensities of each NuRD subunit
band in Sypro-stained SDS-PAGEs of selected sucrose gradient
fractions. To derive a scaling factor to account for the gel stain-
ing properties of each subunit, we took into account the NuRD:
NuDe ratio calculated for each of these fractions above and also
the number of copies of each subunit in the complex (derived
from published stoichiometry data on the NuRD complex (31,
32)). Fig. 6E shows the gel stain scaling factors for each NuRD
subunit, relative to a value of 1 set for HDAC1/2. Using these
values to assess our CHD4-supplemented NuDe samples, we
estimate that the “loading” of CHD4 increased from 22 to 63%
following supplementation.We note that an additional band at
66 kDa co-elutes with our NuRD complex (Fig. 6B). This pro-
FIGURE 2.Cross-linking of purifiedNuRDyields twodistinct bands.When
FOG1 affinity purifications of NuRD are cross-linked using at least 0.5 mM
disuccinimidyl suberate (DSS), two distinct high molecular weight bands are
observed. When a sample with low quantities of CHD4 is cross-linked (NuRD
sample 2, right panel), the intensity of the upper cross-linked band is concom-
itantly reduced. This suggests that the upper cross-linked band is the CHD4-
containing NuRD complex, whereas the lower cross-linked band is the NuDe
complex.
CHD4 Is a Peripheral Component of the NuRD Complex
JULY 22, 2016•VOLUME 291•NUMBER 30 JOURNAL OF BIOLOGICAL CHEMISTRY 15855
 at UQ Library on December 7, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tein has been identified as heat shock 70-kDa protein 1 via tan-
dem mass spectrometry and is a commonly known contami-
nant in affinity purifications (39). This contaminant band is not
present when we instead supplement our NuDe/NuRD com-
plex with FLAG tag-purified CHD4.
To confirm that addition of exogenousCHD4 created a func-
tionally intact NuRD complex, we assessed the nucleosome
remodeling activity of our CHD4-supplemented NuDe/NuRD
preparations (by direct addition of purified CHD4 to NuDe/
NuRD) against unsupplemented NuDe/NuRD preparations
and purified CHD4 only. Real time FRET-based nucleosome
repositioning assays similar to those described by Yang et al.
(40) were carried out. We have previously used this assay to
assess CHD4 nucleosome remodeling activity (41). Briefly, his-
tone octamers containing an Alexa Fluor 488-labeled histone
H2A cysteine mutant (T120C) were assembled on 0W47 DNA
(that is, Widom nucleosome positioning sequence flanked by 0
and 47 bp upstreamanddownstream, respectively) labeledwith
the dark quencher BHQ1, generating asymmetric end-posi-
tionednucleosomes. In these nucleosomes, the proximity of the
FIGURE 3. The NuRD and NuDe complexes migrate as separate complexes under native conditions. A, blue native PAGE of the FOG1 affinity-purified
NuDe/NuRD complexes. Twomajor bands are observed at 900 and 720 kDa, corresponding toNuRD andNuDe, respectively. B, with reducing SDS-PAGE as the
second dimension, two-dimensional blue native SDS-PAGE of a NuDe/NuRD purification shows that the 900-kDa NuRD band has CHD4, whereas the 720-kDa
NuDebanddoesnot. Bothbands contain all otherNuRDcomponents.C, approximatequantificationofNuRDcomponents bymass spectrometry. The900-kDa
NuRDand720-kDaNuDegel bands frombluenative PAGE (Fig. 3A) were cut out, digestedwith trypsin, and then subjected tomass spectrometric analysis. The
resulting protein sequence coverage for each protein from LC-MS/MS is shown, suggesting that the 720-kDa band does not contain significant quantities of
CHD4. The results from two independent NuRD preparations are shown.
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BHQ1 moiety to the Alexa Fluor 488 results in strong quench-
ing of Alexa Fluor 488 fluorescence. Any movement of the
BHQ1 away from the Alexa Fluor 488 dye, such as that arising
from ATP-dependent repositioning by a remodeling enzyme,
results in a robust increase in fluorescence that can be moni-
tored in real time. Supplementation of a NuRD preparation
containing a substoichiometric quantity of endogenous
CHD4 (NuDe/NuRD) with recombinant FLAG-CHD4 (Fig.
7, A, solid gray line, and B) gives rise to a synergistic increase
in ATP-dependent remodeling activity; that is, the activity of
NuDe/NuRD  CHD4 top-up is higher than the summed
activity of NuDe/NuRD-only and CHD4-only (Fig. 7, A, dot-
ted gray line, and B). Similar results were obtained when
classical gel-based nucleosome repositioning assays were
performed; a synergistic increase in ATP-dependent remod-
eling activity was observed for the NuDe/NuRD sample
topped-up with CHD4 (Fig. 7C, lanes 3–5 versus lanes 6–8).
As a control, we show that when an unrelated protein such as
BSA is added to recombinant CHD4, no enhancement of
CHD4 remodeling is observed; in fact, CHD4 activity is
reduced by 20–65% following the addition of 75 nM BSA
(Fig. 7D, black lines versus gray lines). Note that the total
mass of BSA used in this assay was the same as the total mass
of NuDe/NuRD used in Fig. 7 (A—C), suggesting that the
synergistic effect of NuDe/NuRD on CHD4 remodeling
activity is not due to nonspecific carrier protein effects.
FIGURE 4. Sucrose density gradient ultracentrifugation analyses of NuDe/NuRD purifications yield two high molecular weight complexes. A, the
fluorescence of sucrose gradient fractions close to where the NuDe/NuRD complex equilibrates is plotted against depth in the gradient. Two distinct fluores-
cent peaks corresponding to NuDe and NuRD were observed. B, SDS-PAGE analysis of sucrose gradient fractions. Using the presence of CHD4 as a guide, the
NuDecomplex is observed to elute in earlier fractions (19–24),whereas theNuRDcomplex elutes later (25onwards).C, dot blot analysis of sucrosegradient
fractions. Consistent with the SDS-PAGE analysis in B, CHD4 is only detectable from fraction 25 onwards.
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These data reinforce the observation that nativeNuRDprep-
arations from MEL cells carry substoichiometric amounts of
CHD4. In turn, this observation implies that CHD4 lies at a
boundary rather than a core location in the NuRD complex.
Furthermore, it is apparent that the nucleosome remodeling
activity of CHD4 is positively regulated by other subunits of the
NuRD complex.
Discussion
Our Understanding of Remodeler Structure Is Still Limited—
Chromatin remodeling complexes play a variety of essential
roles in the regulation, replication, and expression of the
genome. Their dysregulation is closely linked with a variety of
pathologies, most notably cancer (23, 42, 43). However, the
multisubunit nature of these complexes, combined with the
complexity of their substrate, has hampered efforts to under-
stand the biochemistry underlying their function. The struc-
ture of these complexes will naturally form the basis for their
function, and so an appreciation of the architecture of chroma-
tin remodelers will underpin our understanding of their
activity.
Until very recently, only very low resolution structural infor-
mationwas available for anymultisubunit remodeling complex.
Several structures of RSC from EM data (at25–37 Å) show a
central cavity that seems to be occupied by an added nucleo-
some (9, 10, 13). SWI/SNF cryo-EM data (23 Å) suggest a
roughly spherical structure with a surface cavity that is pro-
posed to accommodate a nucleosome (11), and an EM study of
the human PBAF complex (12) (43–50Å) also suggests a pos-
sible nucleosome binding site. These studies are a valuable first
step, but in no case could subunits of the complex be placed
with any confidence.
The highest resolution analyses of multisubunit chromatin
remodelers have come recently in studies of two related com-
plexes. Tosi et al. (16) built a model from cryo-EM data of the
yeast INO80 complex to a resolution of17 Å. Themodel (Fig.
8A) shows a distinct unit with rough 6-fold symmetry that is
consistent with two stacked hexamers of the ATPase Rvb1/2.
Judging from the EM model and also cross-linking data, this
unit is connected only to the Snf2 family remodeling protein
Ino80, which in turn is connected to Arp5, Nhp10, and Ies2
modules. AnArp8module, which appears to display substantial
mobility, is distally connected to Nhp10. Although EM data
(28 Å) for the related SWR1 complex, also from yeast, unex-
pectedly yielded quite a different model (14), a clear common-
ality between the twomodels was the scaffolding role played by
the Snf2 family remodeling subunit.
CHD4 Is a Peripheral Component of NuRD—The NuRD
complex is perhaps the most enigmatic of the major chromatin
remodeling complexes, from a structural and biochemical per-
spective. The lack of structural data is due in large part to the
restriction of NuRD to multicellular animals and an apparent
inability to reassemble the NuRD complex from recombinantly
expressed subunits.
The literature shows that CHD3, CHD4, and CHD5 can all
act as the remodeling subunit of the NuRD complex. These
proteins share a topology that includes two PHD domains, two
chromodomains, an ATPase domain, and a C-terminal region
of unknown structure. CHD3 andCHD4 are broadly expressed,
whereas CHD5 is present at significantly higher levels in the
brain (44). Drawing from biochemical data and in common
with the INO80/SWR1 complexes, it is widely held that the
CHD remodeler acts as a scaffold around which the NuRD
complex is assembled (18, 33–35).
Our data show clearly that the converse is true: that CHD4
is a peripheral component of the complex. HDAC, MTA,
GATAD2, RBBP, andMBD proteins can assemble into a stable
complex in the absence of a CHD4 family member. This NuDe
complex, like NuRD, can be purified via its affinity for the co-
regulator FOG1 and subsequently sucrose gradient centrifuga-
tion.We also show that theNuDe complex displays unimpaired
deacetylase activity. The full NuRD complex can be reconsti-
tuted through the addition of recombinant CHD4, and this
complex displays ATP-dependent nucleosome remodeling
activity that exceeds the activity of CHD4 alone. Hence, the
observations that theNuDe complex has functional deacetylase
activity and that CHD4 can be supplemented to NuDe to make
NuRD, combined with already published data that the MBD2
and MBD3 subunits are mutually exclusive (5), strongly make
the case that theNuRD complex is relativelymodular. That is, a
core module built around HDAC, MTA, and RBBP subunits
carries histone recognition and modification functions, MBD
subunits contribute DNA targeting ability, and CHD3/4/5 car-
ries out the remodeling. Such a model is also consistent with
data showing that MBD2 binds directly to the HDAC-MTA
core complex (45). This idea also raises the possibility that there
are other modules that we have yet to learn about, considering
that the NuRD complex has been reported to associate with a
number of other proteins, including DOC1, ZMYND8,
ZNF592, and LSD1 (32, 46, 47).
How is CHD4 recruited to the NuDe complex? Chemical
cross-linking data from the Vermeulen laboratory revealed
cross-links betweenCHD3/4 (bothwere observed in their data)
and both GATAD2A/B and MTA1/2 (31). In contrast, no
FIGURE 5.TheNuDe complexhas robust deacetylase activity.Deacetylase
activity was measured for four NuDe/NuRD preparations with a low propor-
tion of CHD4/NuRD (white squares; mean values depicted by dashed line).
Through the course of the deacetylase activity assay, samples were taken at
nine time points, developed, and measured for product fluorescence. The
amount of deacetylase activity observed for the HDAC-positive control (sup-
plied by the assay kit’s manufacturer) is indicated by the black triangles and
dotted line.
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FIGURE 6. NuDe can be supplemented with exogenous recombinant FLAG-CHD4. A, SYPRO-Ruby-stained SDS-PAGE showing expression and
purification of FLAG-CHD4 from HEK293FT cells. Gel lanes (from the left) show molecular weight markers, total soluble fraction from lysed cells
expressing FLAG-CHD4, and purified FLAG-CHD4. B, SYPRO-Ruby-stained SDS-PAGE showing that NuDe/NuRD preparations can be supplemented with
recombinant FLAG-CHD4. Gel lanes (from the left) show molecular weight markers, FOG1 affinity purification of NuDe/NuRD supplemented with
FLAG-CHD4 (by mixing MEL cell nuclear extract with FLAG-CHD4-expressed HEK293FT nuclear extract), and FOG1 affinity purification of NuDe/NuRD
without supplementation. The 66-kDa band (denotedwith an asterisk) in the CHD4-supplementedNuDe/NuRDpurification is the common contaminant
HSPA1A/B. Shown on the right of this panel is an enlarged image of the 200-kDa region of the gel. Three bands corresponding to FLAG-CHD4, native
CHD4, and a degradation product of CHD4 can be seen. C, the fluorescence plots from the NuDe/NuRD sucrose gradient fractions were peak-fitted using
the sum of two Lorentzian curves. The dots represent the actual fluorescence measured, whereas the solid line depicts the fitted curve. Data from three
independent sucrose gradients were used. A representative plot is shown here. D, using the best fit values from C, the molar ratio of NuRD to NuDe was
calculated across different sucrose gradient fractions. Data from three independent sucrose gradients are shown as open circles, and themean values are
depicted by black lines. E, gel stain scaling factors for various NuRD subunits relative to HDAC1/2. To derive gel stain scaling factors for various NuRD
subunits, densitometry data of each NuRD subunit band in SYPRO-Ruby-stained sucrose gradient gels were combined with pre-existing data on the
NuRD stoichiometry and the NuRD:NuDe ratios in D. Six sucrose gradient fraction samples (gray circles) were used for the calculation. Mean values are
depicted by the middle black lines, and the ends of the whiskers show the standard deviation.
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cross-links were observed from CHD3/4 to any of the subunits
HDAC1/2, RBBP4/7, or MBD2/3. The four CHD-MTA cross-
links (CHD3K1067-MTA2K639, CHD4K1390-MTA2K686, CHD4K266-
MTA1K532, andCHD4K266-MTA2K532) all map to theC-terminal
half ofMTA1/2,which is predicted to be largely disordered. Inter-
estingly, the first two of these cross-links implicate residues in
MTA1/2 that lie adjacent to the RBBP4/7 binding motif of those
proteins (30), suggesting that this C-terminal portion of theMTA
proteins might perform a scaffolding function to some degree.
Similarly, the other proteins to which CHD3/4 displayed cross-
links, GATAD2A/B, are predicted to be largely disordered. The
function of GATAD2A/B is completely unknown, although a
small regiondoes formacoiled-coilwithMBD2/3 (29). It is tempt-
ing to speculate that these predicted disordered regions,which are
quite extensive in length (e.g.500of 633 residuesofGATAD2A),
might undergo folding-upon-binding transitions to tether a CHD
remodeler to the NuDe complex. In this context it is notable that
the server D2P2 (48) predicts that the sequence of GATAD2A
contains a large number of predicted molecular recognition fea-
tures: short sequences that are likely to act as protein-binding
motifs (49), adding credence to the idea that it can act as a CHD
recruitment module.
FIGURE 7. Functional NuRD complex can be reconstituted from NuDe plus recombinant CHD4. A, real time nucleosome repositioning traces for NuDe/
NuRD (5ng/l;6.25nM) in theabsence (NuDe/NuRDonly; solidblack line) orpresence (NuDe/NuRDCHD4 top-up; solidgray line) of recombinantCHD4 (0.75
nM). Repositioning activity of CHD4 alone (0.75 nM; dotted black line) and a theoretical trace representing the sumof the NuDe/NuRD-only and CHD4-only data
(dotted gray line) are also shown. The NuDe/NuRD CHD4 top-up trace (solid gray line) is always higher than the sum of NuDe/NuRD only CHD4 only trace
(dotted gray line), suggesting that CHD4 remodeling activity is enhancedwhen it is part of the NuRD complex. The vertical dashed line indicates the addition of
ATP to the reaction. B, quantitation of the relative differences in nucleosome repositioning activity (as shown in A). Total signal change after 70 min was
determined, and the fold change in activity relative to the NuDe/NuRD-only sample was calculated. The NuDe/NuRD only  CHD4 only data points were
obtained by summing the NuDe/NuRD-only and CHD-only data. Data from four independent experiments are shown (gray dots), the median values are
depicted by the gray bars within the boxes, the bottoms and tops of the boxes represent the first and third quartile, and the ends of the whiskers depict the
minimum andmaximum values of all the data. C, gel-based nucleosome repositioning assay for NuDe/NuRD (5 ng/l;6.25 nM) in the absence (NuDe/NuRD
only; lane 1) or presence (NuDe/NuRDCHD4 top-up; lanes 2–5)) of recombinantCHD4 (0.37, 0.75, and1.5nM). Repositioningactivity ofCHD4alone (0.37, 0.75,
and 1.5 nM) are shown in lanes 6–8. In the lower panel, in-gel fluorescence of the repositioned nucleosomebandwas quantified. TheNuDe/NuRDonly samples
are depicted as black bars, and the NuDe/NuRD CHD4 top-up samples are depicted as gray bars, whereas the CHD4 only samples are depicted by hatched
bars. In all instances tested, a synergistic effect on CHD4 remodeling activity was observed in the presence of NuDe/NuRD. D, real time nucleosome reposi-
tioning traces for recombinant CHD4 (0.37, 0.75, and 1.5 nM) in the absence (black solid and dashed lines) or presence of bovine serum albumin (5 ng/l; 75 nM;
gray solid and dashed lines). The vertical dashed line indicates the addition of ATP to the reaction. The data show that at all concentrations of CHD4 tested,
remodeling activity of CHD4 is decreased by20–65% in the presence of BSA (gray arrows), suggesting that the synergistic effect of NuDe/NuRD on CHD4
remodeling activity observed in A–C is specific and not due to carrier protein effects.
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Stoichiometry data for the NuRD complex, also from the
Vermeulen laboratory, have suggested two slightly varying sub-
unit ratios (RBBP:MTA:GATAD2:HDAC:MBD:CHD) of6:3:
2:1:1:1 (32) and 5–6:2–3:2–3:2:2:1 (31). The latter data are
more consistent with the stoichiometries observed in the struc-
tures of the HDAC1-MTA1 and MBD3-GATD2A subcom-
plexes and imply that the complex contains a single CHD sub-
unit that is held in place by two GATAD2A and two MTA
subunits. These interactions are represented in Fig. 8B, which
shows a cartoon of the complex based on the published struc-
tural and stoichiometric data. The regions with known struc-
tures are represented approximately to scale, whereas the
sequence predicted to be disordered is generally not shown.
All of the proteins in the NuRD complex have the capacity to
interact with some component of the nucleosome. The RBBPs
have been shown to have histoneH3 andH4 binding properties
(37, 50); MTA1/2/3 contain BAH domains, which have also
been shown to recognize histone H3 (51); MBD2/3 have DNA-
binding domains that have been shown to bindmethylated and
hydroxymethylated DNA (6, 7), respectively; GATAD2A/B
containGATA-type zinc fingers, which commonly act asDNA-
binding domains, and the enzymes CHD3/4/5 and HDAC1/2
have nucleosomes as their substrates. It is notable that a cross-
link is observed between the MTA2 BAH domain and the
MBD3 MBD domain, juxtaposing these histone and DNA-
binding domains (Fig. 8B). It follows that the overall conforma-
tion of the NuRD complex will need to allow these interactions
to all take place, although not necessarily simultaneously, and
the complex will not necessarily only interact with a single
nucleosome at a given time.
Does CHD4 Have NuRD-independent Functions?—The
peripheral location of CHD4 in the NuRD complex could allow
relatively straightforward addition and removal of CHD4 from
the complex. Shuttling of this type might constitute a mecha-
nism by which the activity of NuRD can be regulated. Similarly,
it might provide a means by which CHD4 can carry out NuRD-
independent functions. It has recently been suggested, for
example, that roles of CHD4 in the DNA damage response and
in cell cycle progressionmight in some cases be independent of
NuRD (19, 41). However, examination of published data does
not reveal any examples in which NuRD-independent activity
has clearly been demonstrated. Nevertheless, one recent study
does demonstrate that an interaction between CHD4 and the
histone methyltransferase Ezh2, a core component of the Poly-
comb repression complex, is essential for the ability of Poly-
comb to repress the geneGFAPduring astroglial differentiation
(52). In an Ezh2-directed affinity purification experiment,
CHD4 was detected by Western blot, but neither MTA2 nor
MBD3 were observed, suggesting that this interaction does not
involve the full NuRD complex. It is notable that the Polycomb
complex does contain RBBP4/7, and it is possible that CHD4-
RBBP4/7 contacts are a feature of both the NuRD and the
CHD4-Polycomb interactions.
The extent to which CHD4 acts independently of NuRD is
therefore still very much an open question. The data described
here demonstrate that severing of the NuRD-CHD4 link
through engineered mutations should be possible without
complete disassembly of the NuRD complex and that the
remaining NuDe complex could still act to modify histone
structure. Targeted disruption of these interactions will permit a
more rigorous delineation of the division between the different
possiblemodes of CHD4 activity. Similarly, the ability to reconsti-
tute theNuRD complex in a straightforwardmanner with recom-
binant CHD4 opens the door to a detailedmechanistic analysis of
CHD4- and NuRD-mediated chromatin remodeling.
Experimental Procedures
Cell Culture—MEL cells were cultured as described previ-
ously (38), with the exception that the medium used for large
scale grow-ups was also supplemented with 50% Ham’s F-12
FIGURE 8. Cartoon representations of the NuRD and INO80 complexes. A, model of the INO80 complex (adapted from Ref. 16). Each module, which
comprises one or more proteins, is indicated. B, cartoon of the NuRD complex. The cartoon is based on the published structural, stoichiometry, and cross-
linking data discussed in the text. Brown, RBBP4/7; red, HDAC1/2; orange, MTA1/2/3; purple, MBD3; dark blue, GATAD2A/B; cyan, CHD3/4/5. B, BAH domain;M,
methyl-binding domain; CC, coiled-coil; P, PHD domain; C, chromodomain; CT, C-terminal domain; A, ATPase domain.
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nutrient mix. Briefly, 10–20-ml seed cultures were maintained
in DMEM (with 4.5 g/liter D-glucose and 110 mg/liter sodium
pyruvate) supplementedwith 5% (v/v) FBS, 50 units/ml penicil-
lin and 50g/ml streptomycin and grown at 37 °C, 5%CO2. For
large scale grow-ups, 250-ml batches of fresh DMEM supple-
mented with 50% (v/v) Ham’s F-12 nutrient mix and 5% (v/v)
FBS were each inoculated with 2  106 cells. The cells were
harvested at a density of 1  106 cells/ml by centrifugation
(300 g, 5min). The typical yield is1 g (wetweight) of cells/liter
of culture. The cells were washed twice in PBS, frozen in liquid
nitrogen, and stored at 80 °C until use. All materials were
purchased from Gibco.
FOG1 Affinity Pulldown—Affinity resin preparation, nuclear
extract preparation, and FOG1 affinity pulldowns were per-
formed as described previously (36, 38). Briefly, for StreptagII-
FOG1(1–15), synthesized peptides were dissolved in NuRD
binding buffer (50 mM HEPES-KOH, 150 mM NaCl, 1% (v/v)
Triton X-100, 1 mM DTT, 1 cOmplete protease inhibitor
(Roche), pH 7.4) and incubated with pre-equilibrated Streptac-
tin beads for 2 h at 4 °C. The beads were then washed with 20
column volumes (CV) of NuRD binding buffer and used for
pulldown experiments.
For GST-FOG1(1–45), Escherichia coli BL21(DE3) cells
containing overexpressed GST-FOG1(1–45) were lysed via
sonication in GST binding buffer (50 mM Tris, 150 mM NaCl,
0.1% -mercaptoethanol, 0.5 mM PMSF, 0.1 mg/ml lysozyme,
10 g/ml DNase I, pH 7.5) and clarified via centrifugation
(16,000 g, 20 min, 4 °C). The cleared supernatant was then
incubated with pre-equilibrated glutathione-Sepharose 4B
beads (GE Healthcare) for 1 h at 4 °C. The beads were then
washed in GST wash buffer (20 CV, 50 mM Tris, 500 mM NaCl,
1% (v/v) Triton X-100, 1 mM DTT, pH 7.5) and then NuRD
binding buffer (10 CV). The beads were then used for pulldown
experiments. MEL cell nuclear extracts were prepared by incu-
bating the thawed cell pellets with hypotonic lysis buffer (5ml/g
of cells; 10 mMHEPES-KOH, 1.5 mMMgCl2, 10 mM KCl, 1 mM
DTT, cOmplete protease inhibitor, pH 7.9) for 20 min at 4 °C.
IGEPAL CA-630 was then added (final concentration, 0.6%
v/v), and the cells were then further incubated for 10 min. The
mixture was then vortexed for 10 s and then centrifuged
(3,300 g, 5 min). The cytoplasmic supernatant was discarded,
and the nuclear pellet was gently washed once with lysis buffer
(0.6% (v/v) IGEPAL CA-630).
The washed nuclear pellet was resuspended in NuRD bind-
ing buffer (3 ml/g of cells), then lysed by sonication, and incu-
bated on ice for 30 min to allow the chromatin to precipitate.
The nuclear extract was then clarified via centrifugation
(16,000  g, 20 min, 4 °C), and the cleared supernatant was
incubated with Streptavidin beads (a preclearing step for
FOG1(1–15) peptide affinity purification) before incubating
with the above FOG1 affinity resins overnight at 4 °C. Postin-
cubation, the nuclear extract was then washed with 20 CV of
NuRD wash buffer 1 (50 mM HEPES-KOH, 500 mM NaCl, 1%
(v/v) Triton X-100, 1 mM DTT, pH 7.4) and then 10 CV of
NuRD wash buffer 2 (50 mMHEPES-KOH, 150 mMNaCl, 0.1%
(v/v) TritonX-100, 1mMDTT, pH7.4). Captured proteinswere
eluted with either StreptagII-FOG1(1–15) elution buffer (10
mM biotin, 50 mM HEPES-KOH, 150 mM NaCl, 0.1% Triton
X-100, 1 mMDTT, pH 8.2) or GST-FOG1(1–45) elution buffer
(50 mM reduced glutathione, 50 mM HEPES-KOH, 150 mM
NaCl, 0.1%TritonX-100, 1mMDTT, pH 8.0) for 30min at 4 °C.
This elution stepwas repeated at least twice to ensure complete
elution.
Disuccinimidyl Suberate Cross-linking—Cross-linking reac-
tionswere initiated by the direct additionof disuccinimidyl suber-
ate (25 mM stock dissolved in anhydrous dimethylformamide) to
the purified NuRD-NuDe complex at a final concentration of 0.1,
0.5, or 1mM.The sampleswere then incubated at 37 °C for 30min
and quenched with 100 mM NH4HCO3 (final concentration, 50
mM) and further incubated at 37 °C for 20min.
Blue Native PAGE and Two-dimensional Blue Native
SDS-PAGE—Purified NuRD/NuDe samples were prepared in
1NativePAGE sample buffer (50mMBis-Tris, 6 NHCl, 50mM
NaCl, 10% (w/v) glycerol, 0.001% (w/v) Ponceau S, pH 7.2) and
loaded onto 3–12% NativePAGETM Novex Bis-Tris gels. The
gels were run at a constant voltage of 100 V for 1 h then at 250
V until the dye front migrated to the end of the gel using 1
NativePAGE running buffer (50 mM Bis-Tris, 50 mM Tricine,
pH 6.8) at the anode and the “light blue” buffer (50mMBis-Tris,
50 mM Tricine, 0.002% (w/v) CoomassieG-250, pH 6.8) at the
cathode. The apparent molecular masses of protein complexes
were estimated by comparison with the NativeMark high
molecular mass markers. For two-dimensional blue native
SDS-PAGE analysis, following the first dimensional blue native
PAGE separation, the blue native gel lane was excised and
equilibrated in 1 SDS sample loading buffer (37 °C, 20 min).
The equilibrated gel lane was then placed into a NuPAGE
Novex 4–12% Bis-Tris gel (well separators were removed
prior) and run at 180 V using 1MES SDS-PAGE buffer.
Sucrose Density Gradient Ultracentrifugation and Dot
Blots—5–35% sucrose density gradients in 50 mM HEPES-
KOH, pH 8.2, and 150 mM NaCl were prepared using the Bio-
compGradientMaster. Prepared gradientswere left standing at
4 °C for at least 1 h prior to usage. Up to 500 l of samples were
then layered on top of each gradient and ultracentrifuged
(186,000  g, 4 °C, 18 h). The gradients were fractionated as
200-l aliquots prior to further downstream analysis. When
using the StreptagII-FOG1(1–15) peptide, the location of the
NuRD and NuDe complexes could be determined by the fluo-
rescence of the fluorescein moiety on the StreptagII-FOG1(1–
15) peptide. Fractions from the sucrose density gradients were
dot blotted and processed as previously described (38).
Mass Spectrometry—Gel bands were prepared essentially as
described previously (38) with minor modifications. Briefly, gel
bands were excised, shredded (53), equilibrated (50 mM
NH4HCO3, 10 min), destained (50 mM NH4HCO3, 50% (v/v)
CH3CN, three or four treatments until all Coomassie has been
removed), and dehydrated (100% CH3CN, 10 min). The dried gel
pieces were then reduced (10 mM DTT, 1 h, 55 °C), alkylated (50
mM iodoacetamide, 20 min, room temperature in the dark),
washed in 50 mM NH4HCO3 (10 min), and dehydrated in 100%
CH3CN (10 min). Trypsin (12 ng/l) was then added to the gel
pieces in an1:50 enzyme:substrate ratio and left to rehydrate (10
min).
The gel pieces were then topped upwith 50mMTris, pH 8, to
just cover the gel pieces. Themixturewas incubated at 37 °C for
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16 h. The supernatant containing the tryptic peptides were
transferred to a fresh tube. The gel pieces were then treated
with 50 l each of the following solutions sequentially for 20
min each before they were removed and pooled with the over-
night supernatant: (i) 0.1% (v/v) trifluoroacetic acid; (ii) 0.1%
(v/v) trifluoroacetic acid, 60% (v/v) CH3CN; and (iii) 100%
CH3CN. The pooled supernatant was then dried, resuspended
in (2% formic acid), and desalted using C18 stage-tips. For LC-
MS/MS, peptides were resuspended in 2% (v/v) acetonitrile,
0.5% (v/v) acetic acid and loaded onto a 20-cm 75-m inner
diameter column packed in-house with 1.9-m C18AQ parti-
cles (Dr. Maisch GmbH HPLC) using an Easy nLC-1000 nano-
HPLC (Proxeon). Peptides were separated using a linear gradi-
ent of 5–30% buffer B over 100 min at 250 nl/min (buffer A 
0.5% (v/v) acetic acid; buffer B  80% (v/v) acetonitrile, 0.5%
(v/v) acetic acid).
Mass analyses were performed using an LTQOrbitrap Velos
Pro or a Q-Exactive plus mass spectrometer (Thermo Scien-
tific). Following each full scan MS1 at 60,000 resolution at 200
m/z (300–1700m/z; 1 106 AGC target), up to 20 most abun-
dant precursor ions were selected forMS/MS (5000 counts; 2
m/z isolation; 10-ms activation time; activation q  0.25; 35.0
normalized collision energy; minimum charge state of 2;
dynamic exclusion of 90 s). Peak lists were generated using Pro-
teome Discoverer v1.4 and submitted to the database search
programMascot (Matrix Science). The datawere searchedwith
oxidation (M), acrylamide (C), and carbamidomethyl (C) as
variable modifications using a precursor-ion and product-ion
mass tolerance of10 ppm and0.6 Da (0.02 Da for Q-Ex-
active plus data), respectively. The enzyme specificity was tryp-
sin with up to two missed cleavages and all taxonomies in the
Swiss-Prot database (May 2014; 545,388 entries)were searched.
A decoy database of reversed sequences was used to estimate
the false discovery rates. To be considered for further analysis,
identified peptides had to be top ranking and statistically signif-
icant (p	 0.05) according to the Mascot expect metric.
Calculation of Gel Stain Intensity Scaling Factors—Three in-
dependent fluorescence plots of sucrose gradient-fractionated
NuDe/NuRDwere subjected to peak fitting in GraphPad Prism
v6.07 using the “sum of two Lorentzian curves” function with
default options. The resulting best fit values were then used to
calculate the proportion of NuRD (versus NuDe) in each
sucrose gradient fraction. Next, the band intensity was mea-
sured by densitometry for each subunit in a SYPRO-Ruby-
stained SDS-PAGE of each sucrose gradient fraction. Stoichi-
ometry data for NuRD subunits from previous reports (31, 32)
were then averaged (giving RBBP:MTA:GATAD2:HDAC:
MBD:CHD ratios of 4.4:2.1:1.6:1:1:0.75) and combinedwith the
densitometry data using the following formula to calculate gel
intensity scaling factors for the various NuRD components rel-
ative to HDAC1/2.
SF   
gel intensity 
stoichiometryintensity of HDAC1/2  (Eq. 1)
The scaling factor for CHD4was furthermodified to account
for the estimated NuRD/NuDe ratio, as calculated above, for
each sucrose gradient fraction.
SF 
CHD4
  
gel intensity 
stoichiometry 
NuRD proportionintensity of HDAC1/2 
(Eq. 2)
Six sucrose gradient fraction samples were used for this cal-
culation. The scaling factor calculated for CHD4 using this
method was then used to assess the relative loading of CHD4 in
complexes created by supplementing NuDe preparations with
recombinant FLAG-CHD4.
Expression and Purification of FLAG-CHD4 in HEK293
Cells—HEK293FT cells were cultured in a humidified atmo-
sphere containing at 37 °C, 5% CO2 in DMEM, supplemented
with 10% (v/v) FBS, 2 mM L-glutamine, 1minimum essential
media nonessential amino acids, 1 mM sodium pyruvate, 50
units/ml penicillin, and 50 g/ml streptomycin. pcDNA3.1
plasmids encoding for FLAG-CHD4 were transfected into
HEK293FT cells at 70% confluence, and CHD4 protein was
expressed for 48–72 h at 37 °C, 5% CO2. Cells were harvested
and resuspended in lysis buffer (50 mM HEPES, 1.5 mM MgCl2,
10 mM KCl, 1 mM DTT, 1 mM PMSF, and 1 cOmplete pro-
tease inhibitor (Roche), pH7.5). The cells were incubated on ice
for 30min, vortexed, and spun down for 5min at 3,300 g. The
supernatant, consisting of the cytoplasmic fraction, was aspi-
rated and discarded. The nuclear pellet was resuspended in
FLAG binding buffer (50 mMHEPES, 0.5 M NaCl, 1 mM EDTA,
1% Triton X-100, 1.5 mM MgCl2, 1 mM DTT, 1 mM PMSF, and
1 cOmplete protease inhibitor (Roche), pH 8). The nuclear
pellet was then homogenized via sonication, incubated on ice
for 30min to allow the chromatin to precipitate, and cleared by
centrifugation for 20 min at 16,000  g at 4 °C. The resulting
nuclear extract was then incubated with -FLAG M2 affinity
gel beads (Sigma-Aldrich) overnight on a rocker at 4 °C. The
next day, the -FLAGM2 beads were washed with FLAGwash
buffer (20 t; 50 mM HEPES, 500 mM NaCl, 0.5% (v/v) IGEPAL
CA-630, 1mMDTT, pH 7.5), and the FLAG-CHD4 protein was
eluted with 300 g/ml 3FLAG peptide (MDYKDHDGDYK-
DHDIDYKDDDDK, in 20 mM HEPES, 150 mM NaCl, 1 mM
DTT, and 10% (v/v) glycerol, pH 7.5; ApexBio). Protein samples
were analyzed by SDS-PAGE and visualized using SYPRO-
Ruby (Life Technologies) and Coomassie stains. All cell culture
materials were purchased from GibcoTM.
FOG1 Affinity Pulldown with Supplemented CHD4—This
purification method was similar to the one described above for
FOG1 affinity pulldown with the exception that either purified
FLAG-CHD4 was added to NuRD/NuDe prebound to FOG1
peptide immobilized on beads (2 h at 4 °C) or HEK293FT
nuclear extract containing expressed FLAG-CHD4 was added
theMEL cell nuclear extract prior to incubation with the FOG1
peptide.
Nucleosome Reconstitutions—Nucleosomes were assembled
on DNA fragments derived from the 601 nucleosome position-
ing sequence (54) and purified recombinantXenopus laevis his-
tone octamers, to give a typical final nucleosome concentration
of 1–2 M. Assembly was performed by salt gradient dialysis
using a double dialysis method (54), as follows. Reactions were
placed in microdialysis buttons, which were placed inside a
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dialysis bag containing 30 ml of 1 TE and 2 M NaCl; the dial-
ysis bag was then dialyzed overnight against 2 liters of 1TE at
room temperature and then against a further 1 L of 1 TE for
3–6 h. The histone octamers used in these reactions were
assembled using standard protocols frompurified recombinant
histones (55), either all as unlabeled proteins or containing
Alexa Fluor 488-labeled H2A.
Labeling of H2A was achieved via the incorporation of a sin-
gle cysteine residue at position 120. A synthetic gene encoding
H2A-T120C was purchased from GeneArt and cloned into a
rhamnose-inducible pRham vector (Lucigen). H2AT120C was
expressed at 37 °C overnight in RosettaTM 2 (DE3) pLysS E. coli
cells in ZYP-5052 autoinduction medium (56) containing an
additional 0.2% (w/v) rhamnose and then purified from inclu-
sion bodies using standard protocols (55). Labeling of purified
H2A-T120C was performed under denaturing conditions in 20
mM Tris, pH 7.0, 7 M guanidine HCl, 5 mM EDTA, and 5 mM
TCEP with a 5-fold molar excess of Alexa Fluor 488 C5
maleimide overnight at 4 °C. The reactions were quenched via
the addition of 30mM -mercaptoethanol and then purified via
gel filtration on a Superdex 200 10/300 column in 20 mM Tris,
pH 7.0, 7 M guanidine HCl, 0.1% -mercaptoethanol. Purified
labeled H2A was dialyzed against deionized water with 0.05%
(v/v) -mercaptoethanol overnight at 4 °C, aliquoted, and
lyophilized for long term storage. Labeling efficiency was
65–70%.
DNA fragments were produced by PCR using MyTaq DNA
polymerase (Bioline) and fluorophore/quencher labeled prim-
ers purchased from Sigma-Aldrich or ATDBio. The PCR prod-
ucts were purified via 0.5TBE 5% polyacrylamide gel electro-
phoresis and electroelution. The notation xWy denotes the
147-bp 601 sequence with flanking DNA of x and y bp on the
upstream and downstream side, respectively.
ATP-driven Nucleosome Remodeling Reactions—Nucleo-
somes were assembled on BHQ1-labeled 0W47 DNA to gener-
ate asymmetric end-positioned nucleosomes. All remodeling
reactions were performed at 37 °C. Real time quenched FRET
remodeling reactions were performed in a FLUOstar OPTIMA
plate reader usingCorning black nonbinding surface half-area
96-well plates and 485P and 520P excitation and emission fil-
ters, respectively. The reactions contained 50 nMBHQ1–0W47
Alexa Fluor 488-labeled nucleosomes, 50 mM Tris, pH 7.5, 50
mM NaCl, 3 mM MgCl2, and the enzyme concentrations indi-
cated in the figures. Reactions were monitored for 5 min prior
to addition of 1 mM ATP to ensure fluorescence changes were
ATP-dependent and then monitored for a further 60–70 min,
with data points recorded every 30–40 s.Gel-based remodeling
reactions were carried out under identical conditions, except
the reactions were stopped by placing themon ice and the addi-
tion of 0.5 g salmon sperm DNA and 4% sucrose prior to
electrophoresis on 0.5TBE5%polyacrylamide gels. Gels were
imaged for Alexa Fluor 488 fluorescence on an FLA-9000 laser
scanner.
HDAC Activity Assays—To assess the HDAC activity of
NuDe, we used fractions from a FOG-based purification that
contained a low proportion of CHD4 (a molar ratio of0.01–
0.02:1 for CHD4 compared with the other subunits, based on
the scaling factors calculated above). HDAC activity was mea-
sured using an HDAC activity assay kit (Cayman Chemical
Company) as per themanufacturer’s instructions. Fluorescence
was quantified using an Infinite M1000 Pro plate reader
(Tecan). The amount of NuDe complex in each assay was
adjusted to contain a total of 25 ng of HDAC. The amount of
HDAC in each sample was estimated from SYPRO-Ruby-
stained SDS-PAGE gels using a known amount of monomeric
BSA as a reference (to allow for comparison of HDAC quanti-
ties between different gels). As a positive control, 100 ng of
manufacturer-supplied HDAC was used. All samples were
assayed twice as technical duplicates.
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Note Added in Proof—During the processing of this manuscript, a
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extending our understanding of NuRD complex architecture. Mil-
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